176 related articles for article (PubMed ID: 18223232)
1. Effects of plasmid-based Stat3-specific short hairpin RNA and GRIM-19 on PC-3M tumor cell growth.
Zhang L; Gao L; Li Y; Lin G; Shao Y; Ji K; Yu H; Hu J; Kalvakolanu DV; Kopecko DJ; Zhao X; Xu DQ
Clin Cancer Res; 2008 Jan; 14(2):559-68. PubMed ID: 18223232
[TBL] [Abstract][Full Text] [Related]
2. Plasmid-based Survivin shRNA and GRIM-19 carried by attenuated Salmonella suppresses tumor cell growth.
Liu YB; Zhang L; Guo YX; Gao LF; Liu XC; Zhao LJ; Guo BF; Zhao LJ; Zhao XJ; Xu DQ
Asian J Androl; 2012 Jul; 14(4):536-45. PubMed ID: 22580637
[TBL] [Abstract][Full Text] [Related]
3. Plasmid-based Stat3-specific siRNA and GRIM-19 inhibit the growth of thyroid cancer cells in vitro and in vivo.
Wang GM; Ren ZX; Wang PS; Su C; Zhang WX; Liu ZG; Zhang L; Zhao XJ; Chen G
Oncol Rep; 2014 Aug; 32(2):573-80. PubMed ID: 24899100
[TBL] [Abstract][Full Text] [Related]
4. [Inhibitory effect of silencing STAT3 gene with short hairpin RNA mediated by polyamidoamine dendrimers on growth of prostate cancer].
Zhao WM; Xiu YC; Xu Y; Wang YM; Cheng ZK; Yu Q; Kong DL
Zhonghua Zhong Liu Za Zhi; 2007 Aug; 29(8):575-9. PubMed ID: 18210874
[TBL] [Abstract][Full Text] [Related]
5. Gene associated with retinoid-interferon-induced mortality-19 suppresses growth of lung adenocarcinoma tumor in vitro and in vivo.
Wang T; Yan XB; Zhao JJ; Ye J; Jiang ZF; Wu DR; Xiao WH; Liu RY
Lung Cancer; 2011 Jun; 72(3):287-93. PubMed ID: 21040996
[TBL] [Abstract][Full Text] [Related]
6. Synergistic effects of eukaryotic co-expression plasmid-based STAT3-specific siRNA and LKB1 on ovarian cancer in vitro and in vivo.
Pan Y; Zhang L; Zhang X; Liu R
Oncol Rep; 2015 Feb; 33(2):774-82. PubMed ID: 25420630
[TBL] [Abstract][Full Text] [Related]
7. Tumor suppressive protein gene associated with retinoid-interferon-induced mortality (GRIM)-19 inhibits src-induced oncogenic transformation at multiple levels.
Kalakonda S; Nallar SC; Gong P; Lindner DJ; Goldblum SE; Reddy SP; Kalvakolanu DV
Am J Pathol; 2007 Oct; 171(4):1352-68. PubMed ID: 17823279
[TBL] [Abstract][Full Text] [Related]
8. Mitochondrial GRIM-19 as a potential therapeutic target for STAT3-dependent carcinogenesis of gastric cancer.
Huang Y; Yang M; Hu H; Zhao X; Bao L; Huang D; Song L; Li Y
Oncotarget; 2016 Jul; 7(27):41404-41420. PubMed ID: 27167343
[TBL] [Abstract][Full Text] [Related]
9. Curcumin synergistically increases effects of β-interferon and retinoic acid on breast cancer cells in vitro and in vivo by up-regulation of GRIM-19 through STAT3-dependent and STAT3-independent pathways.
Ren M; Wang Y; Wu X; Ge S; Wang B
J Drug Target; 2017 Mar; 25(3):247-254. PubMed ID: 27677346
[TBL] [Abstract][Full Text] [Related]
10. The effect of a gene associated with retinoid-interferon-induced mortality 19 (GRIM-19) on STAT3-induced gene expression in renal carcinoma.
Cui L; Meng Q; Wen J; Yan Z; Gao Z; Tian Y; Xu P; Lian P; Yu H
J Biochem; 2018 Oct; 164(4):285-294. PubMed ID: 29961871
[TBL] [Abstract][Full Text] [Related]
11. GRIM-19 represses the proliferation and invasion of cutaneous squamous cell carcinoma cells associated with downregulation of STAT3 signaling.
Wu N; Hui H; Cui L; Yang F
Biomed Pharmacother; 2017 Nov; 95():1169-1176. PubMed ID: 28926927
[TBL] [Abstract][Full Text] [Related]
12. Small interfering RNA survivin and GRIM-19 co-expression salmonella plasmid inhibited the growth of laryngeal cancer cells in vitro and in vivo.
Wen LJ; Gao LF; Jin CS; Zhang HJ; Ji K; Yang JP; Zhao XJ; Wen MJ; Guan GF
Int J Clin Exp Pathol; 2013; 6(10):2071-81. PubMed ID: 24133585
[TBL] [Abstract][Full Text] [Related]
13. Down-regulation of GRIM-19 expression is associated with hyperactivation of STAT3-induced gene expression and tumor growth in human cervical cancers.
Zhou Y; Li M; Wei Y; Feng D; Peng C; Weng H; Ma Y; Bao L; Nallar S; Kalakonda S; Xiao W; Kalvakolanu DV; Ling B
J Interferon Cytokine Res; 2009 Oct; 29(10):695-703. PubMed ID: 19642906
[TBL] [Abstract][Full Text] [Related]
14. Tumor-derived mutations in the gene associated with retinoid interferon-induced mortality (GRIM-19) disrupt its anti-signal transducer and activator of transcription 3 (STAT3) activity and promote oncogenesis.
Nallar SC; Kalakonda S; Lindner DJ; Lorenz RR; Lamarre E; Weihua X; Kalvakolanu DV
J Biol Chem; 2013 Mar; 288(11):7930-7941. PubMed ID: 23386605
[TBL] [Abstract][Full Text] [Related]
15. Upregulation of GRIM-19 suppresses the growth of oral squamous cell carcinoma in vitro and in vivo.
Li M; Li Z; Liang C; Han C; Huang W; Sun F
Oncol Rep; 2014 Nov; 32(5):2183-90. PubMed ID: 25174621
[TBL] [Abstract][Full Text] [Related]
16. Synergistic effects of co-expression plasmid‑based ADAM10-specific siRNA and GRIM-19 on hepatocellular carcinoma in vitro and in vivo.
Liu S; Zhang W; Liu K; Wang Y; Ji B; Liu Y
Oncol Rep; 2014 Dec; 32(6):2501-10. PubMed ID: 25242535
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of miR-423-5p suppressed prostate cancer through targeting GRIM-19.
Lin H; Lin T; Lin J; Yang M; Shen Z; Liu H; Zou Z; Zheng Z
Gene; 2019 Mar; 688():93-97. PubMed ID: 30415005
[TBL] [Abstract][Full Text] [Related]
18. Tumor-suppressive activity of the cell death activator GRIM-19 on a constitutively active signal transducer and activator of transcription 3.
Kalakonda S; Nallar SC; Lindner DJ; Hu J; Reddy SP; Kalvakolanu DV
Cancer Res; 2007 Jul; 67(13):6212-20. PubMed ID: 17616678
[TBL] [Abstract][Full Text] [Related]
19. GRIM-19 mutations fail to inhibit v-Src-induced oncogenesis.
Kalakonda S; Nallar SC; Lindner DJ; Sun P; Lorenz RR; Lamarre E; Reddy SP; Kalvakolanu DV
Oncogene; 2014 Jun; 33(24):3195-204. PubMed ID: 23851499
[TBL] [Abstract][Full Text] [Related]
20. Upregulation of GRIM-19 inhibits the growth and invasion of human breast cancer cells.
Zhang W; Du Y; Jiang T; Geng W; Yuan J; Zhang D
Mol Med Rep; 2015 Aug; 12(2):2919-25. PubMed ID: 25955394
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]